Search
for
Sort by
Research 901–930 of 1000+
- Androgens in cervical cancer: Their role in epidemiology and biology
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- Clinical Characteristics of Hyperandrogenism Include Hirsutism, Polycystic Ovary Syndrome, and Acne: Association with Psychiatric Disease in Women -A Nationwide Population-Based Cohort Study in Taiwan
- Epigallocatechin-Gallate (EGCG): An Essential Molecule for Human Health and Well-Being
- Adult female acne: Clinical and therapeutic particularities (Review)
- Prostaglandins: Key players in immunomodulation of the nervous system
- Pharmacological Activity of Cepharanthine
- Immunohistochemical, pharmacovigilance, and omics analyses reveal the involvement of ATP-sensitive K+ channel subunits in cancers: role in drug–disease interactions
- Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
- Copper-quercetin complexes: methods of study, relevance to cell death pathways, therapeutic applications
- Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS
- A Randomized Cohort Study: Is It Worth the Time to Receive Antiandrogenic Pretreatment Before Ovulation Induction for Women With Polycystic Ovary Syndrome?
- IMPORTANCE OF HAIR GROWTH IN HISUTISM: DIAGNOSIS AND TREATMENT
- The circulating dihydrotestosterone/testosterone ratio is increased by gut microbial 5α-reductase activity in females
- Food and medicine homology: a potential nutritional intervention strategy for post-acute COVID-19 syndrome
- Endocrine and metabolic comorbidities in juvenile-onset systemic lupus erythematosus
- The interplay of oxidative stress and immune dysfunction in Hashimoto’s thyroiditis and polycystic ovary syndrome: a comprehensive review
- Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: e-Posters
- Time Perspective as a Mediator of Depressive Symptoms in Patients with Polycystic Ovary Syndrome
- Testosterone, sex hormone-binding globulin and dehydroepiandrosterone levels and cervical length of Egyptian women with a history of recurrent miscarriages, polycystic ovary syndrome and without the conditions at three stages of pregnancy
- Differences in male and female pattern hair loss based on androgens, estrogen, iron, vitamin D, lipid metabolism, and genetic regulation
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Understanding the Secular Decline in Testosterone: Mechanisms, Consequences, and Clinical Perspectives
- Green and Emerging Microextraction Strategies for Bioanalytical Determination of Hormones: Trends, Challenges, and Applications
- Utilization of Stem Cells in Medicine: A Narrative Review
- Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mechanistic Breakthroughs and Industrial Prospects Driven by Multidisciplinary Collaborative Innovation
- Hyper-Androgenic Symptoms and Infertility in Northern Upper Egypt: Impact of Lifestyle Modification
- Diagnosis of polycystic ovaries syndrome: establishment of reference values of nine hormones on Maglumi X- 8
- Androgen excess disorders remain undiagnosed in one of every four premenopausal women with Type 1 diabetes
- The Nutrient–Skin Connection: Diagnosing Eating Disorders Through Dermatologic Signs